Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) EPS (Weighted Average and Diluted) (2019 - 2025)

Global Medical REIT (GMRE-PB) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.56 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 660.0% year-over-year to -$0.56, compared with a TTM value of -$0.91 through Dec 2025, down 1616.67%, and an annual FY2025 reading of -$0.91, down 1616.67% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.56 for Q4 2025 at Global Medical REIT, down from -$0.37 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.89 in Q4 2023 and bottomed at -$0.56 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.04, with a median of $0.04 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 15818.36% in 2023, then crashed 660.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.05 in 2021, then tumbled by 88.82% to $0.01 in 2022, then soared by 15818.36% to $0.89 in 2023, then crashed by 88.76% to $0.1 in 2024, then plummeted by 660.0% to -$0.56 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GMRE-PB at -$0.56 in Q4 2025, -$0.37 in Q3 2025, and -$0.01 in Q2 2025.